Prescribing data for lecanemab features a boxed warning about prospective threats linked to ARIA. Correct use suggestions discuss approaches to attenuate ARIA hazard, as does AAN advice. With regards to pharmacological interventions, a few rules propose no pharmacologic intervention. Using cholinesterase inhibitors for MCI is contraindicated in a few steerage https://elliottj208fqb8.tkzblog.com/profile